{"id":6052,"date":"2022-08-09T14:09:50","date_gmt":"2022-08-09T12:09:50","guid":{"rendered":"\/uber-betasense\/"},"modified":"2025-03-01T01:52:23","modified_gmt":"2025-03-01T00:52:23","slug":"about-betasense","status":"publish","type":"page","link":"https:\/\/betasense.sites.vh1-schrittweiter.de\/en\/about-betasense\/","title":{"rendered":"About betaSENSE"},"content":{"rendered":"\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t
\n
\n \n \n\n\n \n \n\n
\n
<\/div>\n
<\/div>\n <\/div>\n<\/div>\n <\/div>\n\n
\n
\n
\n\n \n

Our mission.\u00a0<\/h2>

We revolutionise protein diagnostics. As top researchers in the field of protein science, we pursue the goal of detecting neurodegenerative diseases at an early stage in order to prevent their progression to symptomatic conditions.<\/strong><\/h3><\/div>\n\n \n <\/div>\n\n <\/div>\n <\/div>\n\n \n
\n
\n <\/use><\/svg>\n
Learn More About betaSENSE<\/div>\n <\/div>\n <\/div>\n <\/a>\n\n<\/div>\n\n
<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

iRS \u2013 from idea to innovation.<\/strong><\/h2>

The betaSENSE technology<\/a> detects changes in relevant proteins in the body long before the first symptoms of neurodegenerative diseases manifest. Thanks to iRS, the personal risk of disease can be determined precisely on the basis of a small sample of body fluids. This gives physicians and affected persons a valuable head start for therapies \u2013 and at the same time sets the course for the development of new drugs. Making independence in old age a matter of course in the future.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t

\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t
\n

The Management.<\/h3>\n \n \n
\n \n
\n\n\n \nProf. Dr. Klaus Gerwert studied physics in Muenster, Germany, and received his doctorate in biophysical chemistry at the University of Freiburg, Germany.<\/p>\n

After a postdoc at the Max Planck Institute in Dortmund, Germany, and a Heisenberg-fellowship (DFG) at the Scripps Research Institute in La Jolla, USA, he became professor and chair of the Department of Biophysics at the Ruhr University Bochum (RUB) in Germany at the age of 36. He founded the SFB 642 (Collaborative Research Center), Germany, leading it from 2004-2016. Simultaneously, he was a fellow of the Max Planck Society (2009-2017) and external director at the Max Planck Partner Institute in Shanghai (2009-2014), China.<\/p>\n

Since 2018, he has been the founding executive director of the centre of protein diagnostics (PRODI) at Ruhr-University Bochum, Germany (RUB). In 2021, Klaus Gerwert founded betaSENSE GmbH as a spin-off of the Ruhr-University Bochum, managing the company as Chief Executive Officer next to his position as professor in Bochum, Germany.<\/p>\n\" data-desc-position=\"right\" data-zoomable=\"false\" data-width=\"900px\">\n \n \n\n\n \n \n\n

\n
<\/div>\n
<\/div>\n <\/div>\n<\/div>\n\n
\n\n
\n Prof. Dr. Klaus Gerwert\n <\/div>\n\n
\n Founder & CEO\n <\/div>\n\n
\n <\/use><\/svg>\n
Learn more<\/div>\n <\/div>\n \n \n <\/div>\n<\/a>\n\n\n\n <\/div>\n \n
\n\n\n \nNela was born in Belgrade, Serbia, educated in Paris, France, and became a high performing international executive in the pharmaceutical and healthcare sector, successfully building new organizations by fostering diversity and ownership to maximize employee and company potential.<\/p>\n

Nela has led strategic outsourcing solutions from start to finish for the global pharmaceutical industry around the world. This includes defining, developing and managing strategic relationships with several of the top 10 pharmaceutical companies.<\/p>\n

She is passionate about partnering with pharmaceutical and diagnostics companies to develop high-performance global solutions, particularly with regard to the design and implementation of outsourcing governance structures.<\/p>\n

As Chief Operating Officer, Nela manages and is responsible for betaSENSE’s overall operations.<\/p>\n\" data-desc-position=\"right\" data-zoomable=\"false\" data-width=\"900px\">\n \n \n\n\n \n \n\n

\n
<\/div>\n
<\/div>\n <\/div>\n<\/div>\n\n
\n\n
\n Nela Novakovic\n <\/div>\n\n
\n Chief Operating Officer\n <\/div>\n\n
\n <\/use><\/svg>\n
Learn more<\/div>\n <\/div>\n \n \n <\/div>\n<\/a>\n\n\n\n <\/div>\n <\/div>\n <\/div>\n\n
\n\n